Jamali Raika, Khonsari Mahmoodreza, Merat Shahin, Khoshnia Masoud, Jafari Elham, Bahram Kalhori Alireza, Abolghasemi Hassan, Amini Sedighe, Maghsoudlu Mahtab, Deyhim Mohammad-Reza, Rezvan Houri, Pourshams Akram
Digestive Disease Research Center, Medical Sciences/University of Tehran, Shariati Hospital, North Kargar Avenue, Tehran 14117, Iran.
World J Gastroenterol. 2008 May 14;14(18):2867-71. doi: 10.3748/wjg.14.2867.
To determine the prevalence and causes of persistently elevated alanine aminotransferase (ALT) levels among the general population in northern Iran.
A total of 2292 (1376 female, aged 18-75 year), were selected by systematic clustered random sampling from the cities and villages of Gonbad and Kalaleh in Golestan Province and invited to participate in the study. A comprehensive history regarding alcohol drinking and medication was taken. Body mass index (BMI), viral markers and ALT levels were measured. If ALT level was > or = 40 U/L, it was rechecked twice within 6 mo. Those with > or = 2 times elevation of ALT were considered as having persistently elevated ALT level. Non-alcoholic fatty liver disease (NAFLD) was diagnosed based on evidence of fatty liver upon sonography and excluding other etiology.
A total of 2049 (1351 female) patients participated in the study, 162 (7.9%) had elevated ALT level at the first measurement. Persistently elevated ALT level was detected in 64 (3.1%) participants, with 51 (79.6%) with no obvious etiology, six (9.3%) with Hepatitis B, four (6.2%) with Hepatitis C virus (HCV) infection and three (4.6%) with alcoholic hepatitis. The prevalence of NAFLD and alcoholic hepatitis was 2.04% (42 patients) and 0.1% (three), respectively. There was correlation between NAFLD and male gender, overweight, diabetes and living in an urban area [odds ratio = 3.03 (95% CI: 1.6-5.72), 4.21 (95% CI: 1.83-9.68), 2.86 (95% CI: 1.05-7.79) and 2.04 (95% CI: 1.00-4.16) respectively].
NAFLD is the most common cause of persistently elevated serum ALT level among the general population of Iran.
确定伊朗北部普通人群中丙氨酸氨基转移酶(ALT)持续升高的患病率及原因。
通过系统整群随机抽样从戈勒斯坦省贡巴德和卡拉莱的城市及乡村选取了2292名(1376名女性,年龄18 - 75岁)参与者,并邀请其参加研究。收集了关于饮酒和用药的全面病史。测量了体重指数(BMI)、病毒标志物和ALT水平。若ALT水平≥40 U/L,则在6个月内复查两次。ALT升高≥2次者被视为ALT持续升高。非酒精性脂肪性肝病(NAFLD)根据超声检查发现脂肪肝且排除其他病因来诊断。
共有2049名(1351名女性)患者参与研究,首次测量时162名(7.9%)ALT水平升高。64名(3.1%)参与者检测到ALT持续升高,其中51名(79.6%)无明显病因,6名(9.3%)患有乙型肝炎,4名(6.2%)感染丙型肝炎病毒(HCV),3名(4.6%)患有酒精性肝炎。NAFLD和酒精性肝炎的患病率分别为2.04%(42例患者)和0.1%(3例)。NAFLD与男性、超重、糖尿病及居住在城市地区之间存在相关性[比值比分别为3.03(95%置信区间:1.6 - 5.72)、4.21(95%置信区间:1.83 - 9.68)、2.86(95%置信区间:1.05 - 7.79)和2.04(95%置信区间:1.00 - 4.16)]。
NAFLD是伊朗普通人群中血清ALT持续升高的最常见原因。